Vascular Biogenics Ltd (NASDAQ:VBLT)
| 0.164 BATS BZX Real-Time Price As of 9:57am ET |  -0.0098 / -5.64%Today’s Change | 0.10 Today|||52-Week Range 2.20 | +36.67% Year-to-Date |
Latest VBLT News | Press Releases
No recent news for Vascular Biogenics Ltd.
Today’s Trading
| Previous close | 0.17 |
| Today’s open | 0.16 |
| Day’s range | 0.16 - 0.16 |
| Volume | 600 |
| Average volume (3 months) | 3,520,549 |
| Market cap | $14.8M |
Data as of 9:57am ET, 03/29/2023
Growth & Valuation
| Earnings growth (last year) | +18.71% |
| Earnings growth (this year) | -15.56% |
| Earnings growth (next 5 years) | +16.00% |
| Revenue growth (last year) | -16.70% |
| P/E ratio | NM |
| Price/Sales | 170.19 |
| Price/Book | 0.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ITRMIterum Therapeutics ... | 0.00 | 0.00% |
| BPTHBio Path Holdings In... | 0.00 | 0.00% |
| IMNNImunon Inc | 0.00 | 0.00% |
| AKTXAkari Therapeutics P... | -0.02 | -7.69% |
Data as of 10:31am ET, 03/29/2023
Financials
| Last reporting date | March 14, 2023 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $768.0K |
| Annual profit (last year) | -$29.9M |
| Net profit margin | -3,895.83% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Modi’in, Jerusalem |
Forecasts
